CytoCares (Shanghai) Inc.
PrivateLast Round
Strategic
Oct 23, 2025
Est. Valuation
$101.79M
Total Funding Raised
$23.71M
Company Overview
CytoCares (Shanghai) Inc. is a biotechnology company that develops first-in-class therapeutics for cancer and autoimmune disease treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoCares (Shanghai) Inc. Comparables
Compare CytoCares (Shanghai) Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chimagen Biosciences | 87% | |
| EvolveImmune Therapeutics | 78% | |
| Nanjing Leads Biolabs Co Ltd | 76% | |
CytoCares (Shanghai) Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 23, 2025 | ||||
| Series A Extension | May 12, 2023 | ||||
| Series A | Oct 13, 2020 | ||||
| Pre Seed | Jan 2, 2020 | ||||
| Angel | Jun 29, 2016 |
CytoCares (Shanghai) Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shengshijing Asset Management Group | Series A |
| Tailong Investment | Series A Extension |
| Shenzhen Capital Group | Series A Extension |
| Shenzhen Capital Group | Series A Extension |
CytoCares (Shanghai) Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoCares (Shanghai) Inc.'s valuation, stock price, and market status.